Switzerland The CEO of Siemens’ Healthineers Switzerland explains the reasons behind the spinoff of the former Siemens AG segment and elaborates how the Healthineers are positioning themselves to become the main driver of global medical technology trends. In 2015, Siemens made its healthcare segment an independent organization and most recently changed…
Luxembourg Despite its miniscule size, Luxembourg has managed to specialize in three key areas and now has a strong claim to be a global leader in personalized healthcare, e-health and data security, and pharma logistics and air freight. “In championing personalized health, the Luxembourg authorities are indicating that they are both…
Switzerland The general manager of ResMed’s Swiss affiliate explains the company’s efforts to raise the awareness of sleep apnea in the country, and elaborates on how Switzerland can act as a “role model” for the other affiliates of the Group. As much as 80 percent of all sleep apnea cases worldwide…
Philippines Meneleo Hernandez, Jr., President of Multicare, describes Lupin Pharma’s Multicare operations in the Philippines and how their niche business unit strategy and strategic partnerships create a sustainable business model that is driving growth for the branded generics company. As the President of Multicare, could you provide an introduction to Lupin…
Switzerland Nasri Nahas, CEO of Biopôle in Switzerland, discusses his motivations for joining the biotech, and his mission to re-position the organization as a life sciences ecosystem bringing together academia, business, and research. What motivated you to join Biopôle in October 2015? I began my career as a molecular biologist in France…
Mexico Dr. Marco A. Martinez Rios, General Director of the National Institute of Cardiology in Mexico elaborates on the institution’s rich history in Mexico and its contributions to cardiology through research, teaching and treatment. As the general director of the National Institute of Cardiology, could you introduce yourself to our international…
Switzerland The Chairman of Ferring’s Group Operating Committee and Senior Vice President Europe-Canada elaborates on how Europe can be the thinking engine for global pharmaceutical trends. Ferring has bundled the European and Canadian markets into one single region. Could you please introduce us to the full scope of your role…
Singapore In an exclusive interview with Leslie Chua, the General Manager of the Solutions Division at Hitachi Medical Systems, he elaborates on how the division is building on the synergies of all the business units in order to provide healthcare solutions and reach a broader market in the APAC region. As…
Switzerland An expert in the implementation of Swiss federal laws within Switzerland’s constituent cantons, Giovan Maria Zanini discusses the evolution of Swiss pharma regulatory framework and efforts to strengthen and protect the country’s world leading innovation environment. Dr. Zanini, you have been described as “the expert in the cantonal implementation of…
Mexico Alan Smithers, CEO at IFA Celtics, highlights the obesity as a national healthcare challenge and explains the company’s strategy to enlarge its capabilities to cope with the increasing needs of the patients’ and physicians’ communities. Could you please introduce yourself to our international as well as the main activities and…
Switzerland Switzerland may have a world class healthcare system, but small adjustments are needed to ensure incentives for payer and providers are properly aligned with the patient’s ultimate quality and value of care. Dr. Cassis, could you please introduce yourself, with reference to your experience and current responsibilities in the realm…
Switzerland Advances in delivery technology and manufacturing costs have driven a surge of activity in peptide drug development, says Thomas Früh, CEO of Bachem – the largest and most advanced peptide drug CMO in the world. Peptide therapeutics are a hot topic in the pharma industry today – what’s the story…
See our Cookie Privacy Policy Here